~~<i id='969DB00D7A'><strike id='969DB00D7A'><tt id='969DB00D7A'><pre id='969DB00D7A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：fashion 2025-09-28 15:06:55 - browse：37468

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Living organ donors deserve priority status for transplants

hotspot

entertainment

focus

leisure time

focus

AdobeTheU.S.isrunninglowonprimarycarephysicians,withanestimatedshortageofbetween17,800and48,000predi

WSS

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Biden administration plans revamp of organ transplant system

AstraZeneca bets AAV gene therapy will still deliver the goods

Bispecific antibodies are next new thing in cancer immunotherapy

How to fix the rural physician shortage in the U.S.

Neuroscience startup Neumora files for IPO

Wikipedia

focus

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

In science, is the line between industry and academia shifting?

Novavax promises a turnaround & Lilly roils the obesity market

FDA panel gives mixed vote on blood pressure devices

In age of alternative facts, a scholarly course on calling out crap

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Cancer drug shortages should be causing more outrage

Biogen nominates mother of director’s child to replace him on board

23andMe had bad news about my health. I wish a person had delivered it

Radiation, mainstay of cancer treatment, begins a fade

hotspot

Novo: Oral version of Ozempic leads to 15% weight loss

Inside the rise of 'mukbang' eating videos

How to make AI work for medicine

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

FDA approves first new drug developed for postpartum depression

Feds fine Medicare Advantage plans for overcharging members

entertainment

focus

leisure time

focus